Utility of Magnetic Resonance Perfusion Imaging in Quantifying Active Tumor Fraction and Radiation Necrosis in Recurrent Intracranial Tumors

Ashish H. Shah, Manish Kuchakulla, George M. Ibrahim, Eesh Dadheech, Ricardo J. Komotar, Sakir H. Gultekin, Michael E. Ivan

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Ancillary criteria to identify tumor recurrence such as the McDonald criteria or Response Assessment in Neuro-Oncology criteria can provide false diagnoses. Magnetic resonance perfusion (MRP) imaging has been proposed to differentiate post-treatment changes from recurrence. We investigated the utility of MRP to quantify the histological fraction of active tumor (AT), treatment-related changes, and radiation necrosis in recurrent post-treatment intracranial tumors. Methods: We conducted an exploratory single-blind study of patients with intracranial glioblastoma or metastases with previous radiation therapy and MRP before surgery. Biopsy specimens (n = 19) were analyzed for the percentage of AT, radiation necrosis, and treatment effect. Nonparametric Spearman's rho analysis and multivariable analysis of covariance were performed to assess the correlation between quantitative MRP and AT histological fraction. Results: The mean patient age was 58 ± 11.5 years. The mean relative cerebral blood volume (rCBV) and relative cerebral blood flow (rCBF) were 1.33 ± 0.71 and 1.34 ± 0.73, respectively. On analysis of covariance, significant associations were identified between increased rCBF (P = 0.0004) and increased rCBV (P = 0.007) and percentage of AT. A significant interaction was identified between rCBF and rCBV and tumor histological features (glioblastoma vs. metastases; P = 0.003 and P = 0.03, respectively). An rCBF >1 predicted a mean AT fraction of ≥53% for all intracranial tumors and 74% for glioblastoma. Conclusion: MRP can help quantitatively predict tumor recurrence and/or progression for glioblastomas. The AT histological fraction correlated with quantitative radiologic measurements, including rCBV and rCBF. For metastases, MRP might not be as useful in predicting the AT fraction. Clinicians must be judicious with their use of MRP in predicting tumor recurrence and radiation necrosis.

Original languageEnglish (US)
Pages (from-to)e836-e842
JournalWorld neurosurgery
Volume121
DOIs
StatePublished - Jan 1 2019

Fingerprint

Magnetic Resonance Angiography
Necrosis
Radiation
Cerebrovascular Circulation
Neoplasms
Magnetic Resonance Spectroscopy
Perfusion
Glioblastoma
Recurrence
Neoplasm Metastasis
Single-Blind Method
Therapeutics
Radiotherapy

Keywords

  • Glioblastoma
  • Histology
  • Metastasis
  • Recurrence
  • Tumor fraction perfusion

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Utility of Magnetic Resonance Perfusion Imaging in Quantifying Active Tumor Fraction and Radiation Necrosis in Recurrent Intracranial Tumors. / Shah, Ashish H.; Kuchakulla, Manish; Ibrahim, George M.; Dadheech, Eesh; Komotar, Ricardo J.; Gultekin, Sakir H.; Ivan, Michael E.

In: World neurosurgery, Vol. 121, 01.01.2019, p. e836-e842.

Research output: Contribution to journalArticle

Shah, Ashish H. ; Kuchakulla, Manish ; Ibrahim, George M. ; Dadheech, Eesh ; Komotar, Ricardo J. ; Gultekin, Sakir H. ; Ivan, Michael E. / Utility of Magnetic Resonance Perfusion Imaging in Quantifying Active Tumor Fraction and Radiation Necrosis in Recurrent Intracranial Tumors. In: World neurosurgery. 2019 ; Vol. 121. pp. e836-e842.
@article{bcaabcc287e04bdb9bf271bcb77675fc,
title = "Utility of Magnetic Resonance Perfusion Imaging in Quantifying Active Tumor Fraction and Radiation Necrosis in Recurrent Intracranial Tumors",
abstract = "Background: Ancillary criteria to identify tumor recurrence such as the McDonald criteria or Response Assessment in Neuro-Oncology criteria can provide false diagnoses. Magnetic resonance perfusion (MRP) imaging has been proposed to differentiate post-treatment changes from recurrence. We investigated the utility of MRP to quantify the histological fraction of active tumor (AT), treatment-related changes, and radiation necrosis in recurrent post-treatment intracranial tumors. Methods: We conducted an exploratory single-blind study of patients with intracranial glioblastoma or metastases with previous radiation therapy and MRP before surgery. Biopsy specimens (n = 19) were analyzed for the percentage of AT, radiation necrosis, and treatment effect. Nonparametric Spearman's rho analysis and multivariable analysis of covariance were performed to assess the correlation between quantitative MRP and AT histological fraction. Results: The mean patient age was 58 ± 11.5 years. The mean relative cerebral blood volume (rCBV) and relative cerebral blood flow (rCBF) were 1.33 ± 0.71 and 1.34 ± 0.73, respectively. On analysis of covariance, significant associations were identified between increased rCBF (P = 0.0004) and increased rCBV (P = 0.007) and percentage of AT. A significant interaction was identified between rCBF and rCBV and tumor histological features (glioblastoma vs. metastases; P = 0.003 and P = 0.03, respectively). An rCBF >1 predicted a mean AT fraction of ≥53{\%} for all intracranial tumors and 74{\%} for glioblastoma. Conclusion: MRP can help quantitatively predict tumor recurrence and/or progression for glioblastomas. The AT histological fraction correlated with quantitative radiologic measurements, including rCBV and rCBF. For metastases, MRP might not be as useful in predicting the AT fraction. Clinicians must be judicious with their use of MRP in predicting tumor recurrence and radiation necrosis.",
keywords = "Glioblastoma, Histology, Metastasis, Recurrence, Tumor fraction perfusion",
author = "Shah, {Ashish H.} and Manish Kuchakulla and Ibrahim, {George M.} and Eesh Dadheech and Komotar, {Ricardo J.} and Gultekin, {Sakir H.} and Ivan, {Michael E.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.wneu.2018.09.233",
language = "English (US)",
volume = "121",
pages = "e836--e842",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Utility of Magnetic Resonance Perfusion Imaging in Quantifying Active Tumor Fraction and Radiation Necrosis in Recurrent Intracranial Tumors

AU - Shah, Ashish H.

AU - Kuchakulla, Manish

AU - Ibrahim, George M.

AU - Dadheech, Eesh

AU - Komotar, Ricardo J.

AU - Gultekin, Sakir H.

AU - Ivan, Michael E.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Ancillary criteria to identify tumor recurrence such as the McDonald criteria or Response Assessment in Neuro-Oncology criteria can provide false diagnoses. Magnetic resonance perfusion (MRP) imaging has been proposed to differentiate post-treatment changes from recurrence. We investigated the utility of MRP to quantify the histological fraction of active tumor (AT), treatment-related changes, and radiation necrosis in recurrent post-treatment intracranial tumors. Methods: We conducted an exploratory single-blind study of patients with intracranial glioblastoma or metastases with previous radiation therapy and MRP before surgery. Biopsy specimens (n = 19) were analyzed for the percentage of AT, radiation necrosis, and treatment effect. Nonparametric Spearman's rho analysis and multivariable analysis of covariance were performed to assess the correlation between quantitative MRP and AT histological fraction. Results: The mean patient age was 58 ± 11.5 years. The mean relative cerebral blood volume (rCBV) and relative cerebral blood flow (rCBF) were 1.33 ± 0.71 and 1.34 ± 0.73, respectively. On analysis of covariance, significant associations were identified between increased rCBF (P = 0.0004) and increased rCBV (P = 0.007) and percentage of AT. A significant interaction was identified between rCBF and rCBV and tumor histological features (glioblastoma vs. metastases; P = 0.003 and P = 0.03, respectively). An rCBF >1 predicted a mean AT fraction of ≥53% for all intracranial tumors and 74% for glioblastoma. Conclusion: MRP can help quantitatively predict tumor recurrence and/or progression for glioblastomas. The AT histological fraction correlated with quantitative radiologic measurements, including rCBV and rCBF. For metastases, MRP might not be as useful in predicting the AT fraction. Clinicians must be judicious with their use of MRP in predicting tumor recurrence and radiation necrosis.

AB - Background: Ancillary criteria to identify tumor recurrence such as the McDonald criteria or Response Assessment in Neuro-Oncology criteria can provide false diagnoses. Magnetic resonance perfusion (MRP) imaging has been proposed to differentiate post-treatment changes from recurrence. We investigated the utility of MRP to quantify the histological fraction of active tumor (AT), treatment-related changes, and radiation necrosis in recurrent post-treatment intracranial tumors. Methods: We conducted an exploratory single-blind study of patients with intracranial glioblastoma or metastases with previous radiation therapy and MRP before surgery. Biopsy specimens (n = 19) were analyzed for the percentage of AT, radiation necrosis, and treatment effect. Nonparametric Spearman's rho analysis and multivariable analysis of covariance were performed to assess the correlation between quantitative MRP and AT histological fraction. Results: The mean patient age was 58 ± 11.5 years. The mean relative cerebral blood volume (rCBV) and relative cerebral blood flow (rCBF) were 1.33 ± 0.71 and 1.34 ± 0.73, respectively. On analysis of covariance, significant associations were identified between increased rCBF (P = 0.0004) and increased rCBV (P = 0.007) and percentage of AT. A significant interaction was identified between rCBF and rCBV and tumor histological features (glioblastoma vs. metastases; P = 0.003 and P = 0.03, respectively). An rCBF >1 predicted a mean AT fraction of ≥53% for all intracranial tumors and 74% for glioblastoma. Conclusion: MRP can help quantitatively predict tumor recurrence and/or progression for glioblastomas. The AT histological fraction correlated with quantitative radiologic measurements, including rCBV and rCBF. For metastases, MRP might not be as useful in predicting the AT fraction. Clinicians must be judicious with their use of MRP in predicting tumor recurrence and radiation necrosis.

KW - Glioblastoma

KW - Histology

KW - Metastasis

KW - Recurrence

KW - Tumor fraction perfusion

UR - http://www.scopus.com/inward/record.url?scp=85055742740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055742740&partnerID=8YFLogxK

U2 - 10.1016/j.wneu.2018.09.233

DO - 10.1016/j.wneu.2018.09.233

M3 - Article

C2 - 30312826

AN - SCOPUS:85055742740

VL - 121

SP - e836-e842

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

ER -